GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kimia Biosciences Ltd (BOM:530313) » Definitions » Short-Term Capital Lease Obligation

Kimia Biosciences (BOM:530313) Short-Term Capital Lease Obligation : ₹0.00 Mil (As of . 20)


View and export this data going back to 2017. Start your Free Trial

What is Kimia Biosciences Short-Term Capital Lease Obligation?

Kimia Biosciences's Short-Term Capital Lease Obligation for the quarter that ended in . 20 was ₹0.00 Mil.


Kimia Biosciences Short-Term Capital Lease Obligation Historical Data

The historical data trend for Kimia Biosciences's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kimia Biosciences Short-Term Capital Lease Obligation Chart

Kimia Biosciences Annual Data
Trend
Short-Term Capital Lease Obligation

Kimia Biosciences Semi-Annual Data
Short-Term Capital Lease Obligation

Kimia Biosciences Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.


Kimia Biosciences Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kimia Biosciences's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Kimia Biosciences (BOM:530313) Business Description

Traded in Other Exchanges
N/A
Address
Netaji Subhash Place, 974, 9th Floor, Aggarwal Millenium Tower-II, Pitampura, New Delhi, IND, 110 034
Kimia Biosciences Ltd is a company engaged in the manufacturing of bulk drugs. Some of the company's products include Azelnidipine, Deflazacort, Oxaceprol, Seratodast, and Tretinoin among others. Its only operating segment being Pharmaceuticals.

Kimia Biosciences (BOM:530313) Headlines

No Headlines